Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Ovarian cancer and the related topics: MedlinePlus Genetics have been removed from the page, reducing explicit disease tagging and related topics navigation.
    Difference
    0.2%
    Check dated 2026-05-23T10:22:01.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating an updated page version.
    Difference
    0.1%
    Check dated 2026-05-15T23:21:28.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    ClinicalTrials.gov updated the page’s displayed revision/version from v3.5.2 to v3.5.3, without any accompanying change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:52:36.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:31.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:47:46.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:00:49.000Z thumbnail image

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.